
Vincent Medical Holdings Limited
1612.HKHKSEHealthcareMedical - Devices
Latest quote
HK$0.705
−HK$0.005 · -0.70%
1612.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteVincent Medical Holdings Limited is an investment holding company engaged in the comprehensive process of designing, manufacturing, marketing, and distributing medical devices. Its operations are bifurcated into two main business models: providing products for other companies (Original Equipment Manufacturing, or OEM) and selling goods under its own proprietary labels (Original Brand Manufacturing). For its OEM clientele, the company specializes in developing respiratory care products, disposable components for imaging contrast media power injectors, and a range of orthopedic and rehabilitation solutions. Its extensive respiratory portfolio encompasses humidification systems, nCPAP interface systems, dedicated respiratory care units, electronic air-oxygen blenders, and anesthesia systems. In the orthopedic and rehabilitation sector, Vincent Medical offers various adjustable braces engineered for post-injury or post-surgical support, protection, and recovery of musculoskeletal areas. The company also pioneers the development of robotic hand training devices. Under its own brand names, including Inspired Medical, Hand of Hope, and Hypnus, Vincent Medical Holdings Limited distributes its offerings across a wide international market. Key regions include the People's Republic of China, the United States, the Netherlands, Australia, and Japan. Established in 1997 and headquartered in Hung Hom, Hong Kong, the company functions as a subsidiary of Vincent Raya International Limited.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- HK
- CEO
- Cheung Tai Choi
- Listed since
- Jul 13, 2016
- Employees
- 1,468
Market position
52-week range
Current HK$0.705
- Open
- HK$0.705
- Previous close
- HK$0.71
- Volume
- 0
- 0× average
- Average volume
- 394.03K
- Average daily volume
- Market cap
- 458.32M HKD
- Beta
- 0.75
- Market reference 1
- 50-day average
- HK$0.7295
- -3.36% below average
- 200-day average
- HK$0.8554
- -17.58% below average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 461.94M HKD
- P/E (TTM)
- 4.35×
- P/B (TTM)
- 0.69×
- P/S (TTM)
- 0.49×
- EV / EBITDA
- 2.97×
- Earnings yield
- 19.50%
- Free cash flow yield
- 10.21%
- Dividend yield
- 7.09%
Profitability & efficiency
- Gross margin
- 35.10%
- Operating margin
- 13.90%
- Net margin
- 11.19%
- Return on equity
- 15.70%
- Return on assets
- 8.91%
- Return on invested capital
- 12.69%
Financial health
- Debt / equity
- 0.27×
- Current ratio
- 1.96×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (HKD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 932.78M HKD | 800.96M HKD | 717.97M HKD | 629.24M HKD | 777.72M HKD |
| Cost of goods sold | 605.34M HKD | 540.97M HKD | 477.59M HKD | 481.41M HKD | 533.89M HKD |
| Gross profit | 327.44M HKD | 259.99M HKD | 240.39M HKD | 147.83M HKD | 243.83M HKD |
| Research and development | 48.74M HKD | 30.6M HKD | 36.06M HKD | 36.68M HKD | 39.25M HKD |
| Selling, general, and administrative | 148.61M HKD | 151.2M HKD | 139.08M HKD | 133.65M HKD | 125.42M HKD |
| Operating expenses | 197.75M HKD | 180.32M HKD | 174.61M HKD | 176.35M HKD | 164.38M HKD |
| Interest income | 1.3M HKD | 1.2M HKD | 697K HKD | 510K HKD | 382K HKD |
| Interest expense | 899K HKD | 1.36M HKD | 1.68M HKD | 2.85M HKD | 2.43M HKD |
| Depreciation and amortization | 21.32M HKD | 22.19M HKD | 38.33M HKD | 40.95M HKD | 40.06M HKD |
| Operating income | 129.7M HKD | 79.67M HKD | 65.78M HKD | −11M HKD | 74.49M HKD |
| Net income | 104.38M HKD | 69.17M HKD | 57.28M HKD | −17.4M HKD | 60.7M HKD |
Company facts updated Aug 24, 2026.
Corporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
HK$0.041
2025 complete year-68.5% since 2021
2026 partial: HK$0.026
HK$0.13
2,021
HK$0.05
2,022
HK$0.031
2,024
HK$0.041
2,025
HK$0.026
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | May 26, 2026 | HK$0.026Semi-Annual | May 28, 2026 | Jun 18, 2026 |
Dividend | Sep 2, 2025 | HK$0.024Semi-Annual | Sep 4, 2025 | Sep 26, 2025 |
Dividend | May 27, 2025 | HK$0.017Semi-Annual | May 28, 2025 | Jun 20, 2025 |
Dividend | Sep 3, 2024 | HK$0.016Semi-Annual | Sep 5, 2024 | Sep 27, 2024 |
Dividend | May 28, 2024 | HK$0.015Semi-Annual | May 30, 2024 | Jun 21, 2024 |
Dividend | Sep 5, 2023 | HK$0.0125Annual | Sep 6, 2023 | Sep 29, 2023 |
Ex-dividend May 26, 2026
HK$0.026
Semi-Annual
Record May 28, 2026 · Payment Jun 18, 2026
Ex-dividend Sep 2, 2025
HK$0.024
Semi-Annual
Record Sep 4, 2025 · Payment Sep 26, 2025
Ex-dividend May 27, 2025
HK$0.017
Semi-Annual
Record May 28, 2025 · Payment Jun 20, 2025
Ex-dividend Sep 3, 2024
HK$0.016
Semi-Annual
Record Sep 5, 2024 · Payment Sep 27, 2024
Ex-dividend May 28, 2024
HK$0.015
Semi-Annual
Record May 30, 2024 · Payment Jun 21, 2024
Ex-dividend Sep 5, 2023
HK$0.0125
Annual
Record Sep 6, 2023 · Payment Sep 29, 2023
1612.HK peers
Continue in GoAI
Research 1612.HKresearch.disclaimer





